Código QR (código de barras bidimensional)

Safety of Tocilizumab in COVID-19 Patients and Benefit of Single-Dose: The Largest Retrospective Observational Study

Severe acute respiratory coronavirus-2 (SARS-CoV-2) still presents a public threat and puts extra strain on healthcare facilities. Without an effective antiviral drug, all available treatment options are considered supportive. Tocilizumab as a treatment option has to date shown variable results. In...

ver descrição completa

Na minha lista:
Principais autores: Ayman M. Al-Qaaneh, Fuad H. Al-Ghamdi, Sayed AbdulAzeez, J. Francis Borgio
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-03-01
coleção:Pharmaceutics
Assuntos:
COVID-19 patient
tocilizumab
mortality
treatment
ICU admission
monoclonal antibody
Acesso em linha:https://www.mdpi.com/1999-4923/14/3/624
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados